News Snapshot:
Cepi earmarks millions of dollars for Chendgu-based firm to advance candidate to next phase of trials Company also plans to use money to scale up manufacturing of doses Cepi earmarks millions of dollars for Chendgu-based firm to advance candidate to next phase of trials. Hundreds of millions of Covid-19 vaccine doses developed by a Chinese pharmaceutical company could be included in a World Health Organization (WHO) plan for fair access to vaccines, following a deal announced on Tuesday. Chengdu-based vaccine maker Sichuan Clover Biopharmaceuticals, Inc will receive up to US$328 million from the Coalition for Epidemic Preparedness Innovations (Cepi), an...
